XERIS PHARMA Stock Price (NASDAQ:XERS)

Add to My Stocks
$20.09 $0.86 (4.11%) XERS stock closing price Sep 21, 2018 (Closing)
Prev Close* : $20.95
Market Cap:
$436.12M
Day Low: $19.4
52 Week Low: $15.75
Open: $21.11
Volume: -
Day High: $21.11
52 Week High: $27.98
Dividend:
0.00

Latest Stock Market News

Latest Articles

XERS Stockcharts

View XERS PE ratio, PS ratio stocks charts and compare with peers.
XERS Chart
Note: Compare XERIS PHARMA stock price history with the index and industry peers.

XERIS PHARMA Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

XERIS PHARMA Returns

ROE
(return on equity)

XERIS PHARMA Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

XERS Industry Peers

Company Price Change (%)
Rigel Pharma (RIGL)3.240.08 (2.41%)
Collegium Pharma (COLL)15.30.38 (2.42%)
Odonate Therpts (ODT)21.010.64 (3.14%)
Translate Bio (TBIO)9.990.37 (3.57%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
SIGA Technologies (SIGA)7.230.48 (7.11%)
AcelRx Pharma (ACRX)3.950.25 (6.76%)
ChemoCentryx (CCXI)12.910.54 (4.37%)
Infinity Pharma (INFI)2.40.09 (3.9%)
Redhill Biopharma (RDHL)8.040.14 (1.77%)
Adamis Pharma (ADMP)3.10.05 (1.64%)
BioSpecifics Technologies (BSTC)58.520.78 (1.35%)
Top gainers from Medical-Drugs industry
* As of Sep 21, 2018
CompanyPriceChange (%)
Lannett Co (LCI)50.5 (9.09%)
Neptune Tech. & Bio. (NEPT)4.340.38 (8.05%)
Tetraphase Pharmaceuticals (TTPH)2.920.24 (7.59%)
CORREVIO PHARMA (CORV)4.020.27 (6.29%)
Arrowhead Pharma (ARWR)17.771.11 (5.88%)
Galectin Therapeutics (GALT)6.530.4 (5.77%)
Esperion Therapeutics (ESPR)43.162.59 (5.66%)
Top losers from Medical-Drugs industry
* As of Sep 21, 2018

XERIS PHARMA Stock News - Partner Headlines

XERIS PHARMA Financial Statements

XERIS PHARMA Stock Message Board

As of last trading day, XERIS PHARMA stock price was $20.09. The total market value as denoted by $436.12M for XERIS PHARMA, is the market value of the company's outstanding shares. XERIS PHARMA valuation can be guaged using various valuation metrics like the price to earnings ratio.

For recognizing and analyzing the real performance of XERIS PHARMA stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume of shares traded stood at 1,011,232 on the last trading day, as is evident from XERIS PHARMA stock chart, and XERS stock quote data. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. XERIS PHARMA does not pay dividends. To check the historical stock price movement, all time high, and all time low of XERS, view XERIS PHARMA stock price history.